Richard Denk is Head Sales Containment at SKAN AG, www.skan.ch, Richard.Denk@skan.ch.
Using Robotics in the Aseptic Manufacturing Facility of the Future
Several steps need be taken to achieve lights-out, fully automated operations.
Understanding the Impact of Annex 1 on Isolator Operation
Decontamination, automation, and containment are important considerations for aseptic manufacturing in isolators.
Understanding the Impact of Annex 1 on Isolator Design
An optimal engineering design is crucial for aseptic operation and cleaning.
Understanding Containment
The new ISPE Containment Manual is a summary of the process involved in the manufacture of highly active or highly hazardous pharmaceutical substances.
Best Practices for Handling Antibody Drug Conjugates
Manufacturing of antibody drug conjugates requires high-containment solutions, such as high-performance aseptic isolators.